Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-κB

Head and Neck

Volumn 22, Issue 8, 2000, Pages 748-759

  Kato, Taiji ^a   Duffey, Dianne C ^a   Ondrey, Frank G ^a   Dong, Gang ^a   Chen, Zhong ^a   Cook, John A ^a   Mitchell, James B ^a   Van Waes, Carter ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

Cisplatin; Glutathione; NF B; Radiation; Squamous cell carcinoma

Indexed keywords

BUTHIONINE SULFOXIMINE; CISPLATIN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CELL SURVIVAL; CHEMOSENSITIVITY; CYTOTOXICITY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; CISPLATIN; DNA, COMPLEMENTARY; DNA, NEOPLASM; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE; HUMANS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; RADIATION DOSAGE; RADIATION TOLERANCE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0033750514     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0347(200012)22:8<748::AID-HED2>3.0.CO;2-6     Document Type: Article

References (65)

1. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer
2. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma
3. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo
4. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
5. Simultaneous radiochemotherapy versus radiotherapy alone in advance head and neck cancer: A randomized multicenter study
6. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
7. Induction chemotherapy for organ preservation in advanced laryngeal cancer: Is there a role?
8. Workshop report: Organ preservation strategies in advanced head and neck cancer-current status and future directions
9. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis
10. Glutathione-associated enzymes in anticancer drug resistance
11. The glutathione-S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance
12. Cellular and molecular determinants of cisplatin resistance
13. Relationship of glutathione and glutathione-S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines
14. Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines
15. Immunohistochemical staining for glutathione S -transferase predicts response to platinum-based chemotherapy in head and neck cancer
16. Augmentation of Adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
17. Depletion of glutathione in normal and malignant human cells
18. Chemosensitivity of head and neck squamous carcinoma cell lines is not primarily correlated with glutathione level but is modified by glutathione depletion
19. Clinical studies of reversal of drug resistance based on glutathione
20. Radiation sensitivity and study of glutathione and related enzymes in human colorectal cancer cell lines
21. Glutathione modulation in cancer treatment: Will it work?
22. Effect of L-buthionine sulfoximine on the radiation response of human renal carcinoma cell lines
23. Ionizing radiation and shortwave UV activate NF-κB through two distinct mechanisms
24. Induction of nuclear factor κB after low-dose ionizing radiation involves a reactive oxygen intermediate signaling pathway
25. TNF- and cancer therapy-induced apoptosis potentiation by inhibition of NF-κB Science
26. Constitutive activation of transcription factors NF-κB, AP-1 and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express proinflammatory and proangiogenic cytokines
27. Expression of a dominant negative mutant Inhibitor-κBα of nuclear factor-κB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression and tumor growth in vivo
28. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck
29. 11p Deletions and breakpoints in squamous cell carcinoma: Association with altered reactivity with the UM-E7 antibody
30. Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression
31. Cellular glutathione and thiol measurements from surgically resected human lung tumor and normal lung tissue
32. Suppression of TNF-α-induced apoptosis by NF-κB
33. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
34. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing
35. Mean inactivation dose: A useful concept for intercomparison of human cell survival curves
36. The response of hypoxic cells in m murine tumors to treatment with cisplatin and xrays
37. Role of glutathione, glutathione-S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines
38. Glutathione export by human lymphoid cells: Depletion of glutathione by inhibition of its synthesis decreases export and increases sensitivity to irradiation
39. Radiation response of drug-resistant variants of a human breast cancer cell line: The effect of glutathione depletion
40. Melphalan resistant human ovarian tumour cells are cross-resistant to photons, but not to high LET neutrons
41. Role of glutathione in the aerobic radiation response
42. The role of glutathione in radiation and drug induced cytotoxicity
43. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols
44. Survival curves of glutathione synthetase deficient human fibroblasts: Correlation between radiosensitivity in hypoxia and glutathione synthetase activity
45. Glutathione manipulation and the radiosensitivity of human tumour and fibroblast cell lines
46. Inhibition of NF-κB, clonogenicity, and radiosensitivity of human cancer cells
47. Inhibition of transcription factor nuclear factor-kappa βα attenuates resistance of human head and neck squamous cell carcinoma to TNF-α caspase-mediated cell death
48. Enhanced radio-sensitivity by inhibition of nuclear factor κB activation in human malignant glioma cells
49. Inhibition of homologue of Slimb (HOS) function sensitizes human melanoma cells for apoptosis
50. Control of inducible chemoresistance enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB
51. Stable Inhibition of nuclear factor κB in cancer cells does not increase sensitivity to cytotoxic drugs
52. Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines
53. Radiosensitivity of drug-resistant human tumour xenografts
54. Chinese hamster pleiotropic multidrug-resistant cells are not radioresistant
55. The host environment promotes the constitutive activation of NF-κB and proinfiammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma
56. Tumor necrosis factor increases hepatocellular glutathione by transcriptional regulation of the heavy subunit chain of gamma-glutamylcysteine synthetase
57. Regulation of gamma-glutamylcysteine synthetase expression in response to oxidative stress
58. Modulation of NF-κB and Bcl-2 in apoptosis induced by cisplatin in HeLa cells
59. Co-expression of gamma-glutamylcysteine synthetase sub-units in response to cisplatin and doxorubicin in human cancer cells
60. Correlated expression of glutathione S-transferase-pi and c-Jun or other oncogene products in human squamous cell carcinomas of the head and neck: Relevance to relapse after radiation therapy
61. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation
62. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival
63. The prosurvival BC1-2 homolog Bf1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis
64. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues